Sandra L Jackson1, Qi Long2, Mary K Rhee3, Darin E Olson3, Anne M Tomolo3, Solveig A Cunningham4, Usha Ramakrishnan4, K M Venkat Narayan4, Lawrence S Phillips3. 1. Atlanta VA Medical Center, Decatur, GA, USA; Nutrition and Health Sciences, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, USA. Electronic address: sandrajackson@alum.emory.edu. 2. Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA. 3. Atlanta VA Medical Center, Decatur, GA, USA; Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. 4. Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Abstract
BACKGROUND: Programmes for lifestyle change are aimed at improving health but little is known about their effectiveness in clinical settings. The Veterans Health Administration (VA) MOVE! lifestyle change programme is the largest in the USA. We investigated whether participation in MOVE! is associated with reduced incidence of diabetes. METHODS: We did a retrospective observational analysis of data from VA databases in overweight patients and obese patients with a weight-related disorder who had undergone at least 3 years of continuous outpatient care in 2005-12. We used generalised estimating equations to assess characteristics associated with MOVE! participation, and Cox's proportional hazards regression to analyse the association between participation and diabetes incidence. FINDINGS: Of 1·8 million eligible individuals, 238 540 (13%) participated in the MOVE! programme. 19 367 (1% overall, 8% of participants) met criteria for intense and sustained participation (at least eight sessions within 6 months over at least a 4-month span), which was associated with greater weight loss at 3 years than low-intensity or no participation (-2·2% vs -0·64% or 0·46%). Compared with non-participation, incidence of diabetes was reduced by intense and sustained participation (hazard ratio 0·67, 95% CI 0·61-0·74) and low-intensity participation (0·80, 0·77-0·83) in MOVE!. These patterns were consistent across sex, ethnic origin, and age. Participation was most beneficial in patients with high BMI or high random glucose concentrations at baseline (both pinteraction<0·0001). INTERPRETATION: Participation in the MOVE! programme was associated with weight loss and reduced incidence of diabetes, but the rate of participation was low and, therefore, selection bias could have exaggerated these effects. FUNDING: US Department of Veterans Affairs, National Institutes of Health.
BACKGROUND: Programmes for lifestyle change are aimed at improving health but little is known about their effectiveness in clinical settings. The Veterans Health Administration (VA) MOVE! lifestyle change programme is the largest in the USA. We investigated whether participation in MOVE! is associated with reduced incidence of diabetes. METHODS: We did a retrospective observational analysis of data from VA databases in overweight patients and obesepatients with a weight-related disorder who had undergone at least 3 years of continuous outpatient care in 2005-12. We used generalised estimating equations to assess characteristics associated with MOVE! participation, and Cox's proportional hazards regression to analyse the association between participation and diabetes incidence. FINDINGS: Of 1·8 million eligible individuals, 238 540 (13%) participated in the MOVE! programme. 19 367 (1% overall, 8% of participants) met criteria for intense and sustained participation (at least eight sessions within 6 months over at least a 4-month span), which was associated with greater weight loss at 3 years than low-intensity or no participation (-2·2% vs -0·64% or 0·46%). Compared with non-participation, incidence of diabetes was reduced by intense and sustained participation (hazard ratio 0·67, 95% CI 0·61-0·74) and low-intensity participation (0·80, 0·77-0·83) in MOVE!. These patterns were consistent across sex, ethnic origin, and age. Participation was most beneficial in patients with high BMI or high random glucose concentrations at baseline (both pinteraction<0·0001). INTERPRETATION: Participation in the MOVE! programme was associated with weight loss and reduced incidence of diabetes, but the rate of participation was low and, therefore, selection bias could have exaggerated these effects. FUNDING: US Department of Veterans Affairs, National Institutes of Health.
Authors: Sandeep R Das; Linda S Kinsinger; William S Yancy; Anthea Wang; Eileen Ciesco; Mary Burdick; Steven J Yevich Journal: Am J Prev Med Date: 2005-04 Impact factor: 5.043
Authors: Jennifer G Twombly; Qi Long; Ming Zhu; Lisa-Ann Fraser; Darin E Olson; Peter W F Wilson; K M Venkat Narayan; Lawrence S Phillips Journal: Diabetes Res Clin Pract Date: 2010-11-26 Impact factor: 5.602
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: Jaana Lindström; Anne Louheranta; Marjo Mannelin; Merja Rastas; Virpi Salminen; Johan Eriksson; Matti Uusitupa; Jaakko Tuomilehto Journal: Diabetes Care Date: 2003-12 Impact factor: 19.112
Authors: Linda S Kinsinger; Kenneth R Jones; Leila Kahwati; Richard Harvey; Mary Burdick; Virginia Zele; Steven J Yevich Journal: Prev Chronic Dis Date: 2009-06-15 Impact factor: 2.830
Authors: Jessica Y Breland; Ciaran S Phibbs; Katherine J Hoggatt; Donna L Washington; Jimmy Lee; Sally Haskell; Uchenna S Uchendu; Fay S Saechao; Laurie C Zephyrin; Susan M Frayne Journal: J Gen Intern Med Date: 2017-04 Impact factor: 5.128
Authors: Sandra L Jackson; Sandra Safo; Lisa R Staimez; Qi Long; Mary K Rhee; Solveig A Cunningham; Darin E Olson; Anne M Tomolo; Usha Ramakrishnan; K M Venkat Narayan; Lawrence S Phillips Journal: Am J Prev Med Date: 2016-12-06 Impact factor: 5.043
Authors: Matthew J Magee; Anjali Khakharia; Neel R Gandhi; Cheryl L Day; Hardy Kornfeld; Mary K Rhee; Lawrence S Phillips Journal: Diabetes Care Date: 2022-04-01 Impact factor: 17.152
Authors: Assiamira Ferrara; Monique M Hedderson; Susan D Brown; Cheryl L Albright; Samantha F Ehrlich; Ai-Lin Tsai; Bette J Caan; Barbara Sternfeld; Nancy P Gordon; Julie A Schmittdiel; Erica P Gunderson; Ashley A Mevi; William H Herman; Jenny Ching; Yvonne Crites; Charles P Quesenberry Journal: Diabetes Care Date: 2015-12-09 Impact factor: 19.112
Authors: Sandra L Jackson; Lisa R Staimez; Sandra Safo; Qi Long; Mary K Rhee; Solveig A Cunningham; Darin E Olson; Anne M Tomolo; Usha Ramakrishnan; Venkat K M Narayan; Lawrence S Phillips Journal: J Diabetes Complications Date: 2017-06-06 Impact factor: 2.852
Authors: Uma Mudaliar; Azadeh Zabetian; Michael Goodman; Justin B Echouffo-Tcheugui; Ann L Albright; Edward W Gregg; Mohammed K Ali Journal: PLoS Med Date: 2016-07-26 Impact factor: 11.069